| NDC Code | 0078-0834-30 |
|---|
| Package Description | 1 BOTTLE in 1 CARTON (0078-0834-30) / 240 SPRAY, METERED in 1 BOTTLE |
|---|
| Product NDC | 0078-0834 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Patanase |
|---|
| Non-Proprietary Name | Olopatadine Hydrochloride |
|---|
| Dosage Form | SPRAY, METERED |
|---|
| Usage | NASAL |
|---|
| Start Marketing Date | 20080428 |
|---|
| End Marketing Date | 20230831 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA021861 |
|---|
| Manufacturer | Novartis Pharmaceuticals Corporation |
|---|
| Substance Name | OLOPATADINE HYDROCHLORIDE |
|---|
| Strength | 600 |
|---|
| Strength Unit | ug/1 |
|---|
| Pharmacy Classes | Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC] |
|---|